Mondrian Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$157M Buy
319,001
+21,269
+7% +$11.5M 2.35% 15
2025
Q4
$173M Sell
297,732
-6,613
-2% -$3.74M 2.85% 11
2025
Q3
$148M Buy
+304,345
New +$142M 2.46% 12
2025
Q1
$107M Buy
214,506
+127,357
+146% +$69M 1.83% 29
2024
Q4
$52.1M Buy
+87,149
New +$47.9M 0.86% 44

Other funds holding TMO

Mondrian Investment Partners's TMO Position: Q1 2026 in Review

Mondrian Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 7.1% in Q1 2026, buying an estimated $11.5M and bringing the position to 319,001 shares worth $157M. The position accounts for 2.35% of the portfolio, ranked #15.

Mondrian Investment Partners first reported a position in TMO in Q4 2024 and has held it in 5 quarters since. The position peaked at $173M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mondrian Investment Partners held 319,001 shares of Thermo Fisher Scientific worth $157M as of Q1 2026.
  • Mondrian Investment Partners bought 21,269 Thermo Fisher Scientific shares in Q1 2026, an estimated $11.5M.
  • Thermo Fisher Scientific made up 2.35% of Mondrian Investment Partners's portfolio in Q1 2026, its #15 holding.
  • Mondrian Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 5 quarters since.
  • Mondrian Investment Partners's Thermo Fisher Scientific position peaked at $173M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mondrian Investment Partners's 13F filing for Q1 2026, filed 29 Apr 2026.